Booster Therapeutics’s ^Investor

Operator of a biotech company intended to develop drug modalities to eliminate toxic accumulations. The company targets a cellular system that regulates and maintains cellular homeostasis and reinstates balance within cells, enabling healthcare professionals to prevent and treat diseases of Therapeutics 2025 : Valuation, Funding ...?